Tilray Brands, Inc. (TLRY) Shareholder Equity
- 2026-05-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $132.00K; Additional Paid in Capital, Common StockUSD $6.63B; Treasury Stock, Common, ValueUSD $0.00.
- 2026-02-28: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $116.00K; Additional Paid in Capital, Common StockUSD $6.52B; Treasury Stock, Common, ValueUSD $0.00.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $106.00K; Additional Paid in Capital, Common StockUSD $6.40B; Treasury Stock, Common, ValueUSD $0.00.
- 2025-11-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $116.00K; Additional Paid in Capital, Common StockUSD $6.51B; Treasury Stock, Common, ValueUSD $0.00.
Tilray Brands, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Split USD | Noncontrolling Interest, Decrease from Deconsolidation USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Partners' Capital Account, Contributions USD | Noncontrolling Interest in Variable Interest Entity USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $0.00 | $132.00K | $6.63B | $0.00 | $-44.23M | $-4.97B | $1.61B | $1.59B | 589.22K | (m) | 12 month · $31.70M | 12 month · $159.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-02-28 | $0.00 | $116.00K | $6.52B | $0.00 | $-44.20M | $-4.92B | $1.56B | $1.53B | 321.39K | (m) | 3 month · $9.18M | 3 month · $159.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $106.00K | $6.40B | $0.00 | $-43.06M | $-4.85B | $1.51B | $1.49B | 200.42K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-11-30 | $0.00 | $116.00K | $6.51B | $0.00 | $-39.29M | $-4.89B | $1.58B | $1.55B | 321.39K | (m) | 3 month · $7.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-08-31 | $0.00 | $111.00K | $6.43B | $0.00 | $-43.23M | $-4.85B | $1.54B | $1.52B | 3.21M | (m) | 3 month · $5.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-05-31 | $0.00 | $106.00K | $6.40B | $0.00 | $-43.06M | $-4.85B | $1.51B | $1.49B | 200.42K | (m) | 12 month · $24.29M | (m) | 12 month · $2.18M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.70B | 9.62M | (m) | 3 month · $4.04M | (m) | 3 month · $3.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $99.00K | $6.36B | $0.00 | $-52.94M | $-3.57B | $2.73B | $2.70B | 9.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-11-30 | $0.00 | $93.00K | $6.31B | $0.00 | $-47.96M | $-2.78B | $3.47B | $3.45B | 3.68M | (m) | 3 month · $7.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-08-31 | $0.00 | $88.00K | $6.22B | (m) | $-39.88M | $-2.70B | $3.48B | $3.48B | (m) | (m) | 3 month · $6.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-05-31 | $0.00 | $83.00K | $6.15B | $0.00 | $-43.50M | $-2.66B | $3.44B | $3.44B | 0.00 | 12 month · $3.95M | 12 month · $31.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-02-29 | $0.00 | $77.00K | $6.03B | (m) | $-43.19M | $-2.63B | $3.36B | $3.34B | (m) | (m) | 3 month · $8.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $83.00K | $6.15B | $0.00 | $-43.50M | $-2.66B | $3.44B | $3.44B | 0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-11-30 | $0.00 | $73.00K | $5.94B | (m) | $-38.37M | $-2.54B | $3.37B | $3.39B | (m) | (m) | 3 month · $8.20M | (m) | (m) | (m) | (m) | 3 month · $1.67M | (m) | (m) | (m) |
| 2023-08-31 | $0.00 | $72.00K | $5.91B | (m) | $-43.56M | $-2.49B | $3.38B | $3.40B | (m) | 3 month · $3.95M | 3 month · $8.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-05-31 | $0.00 | $66.00K | $5.78B | (m) | $-46.61M | $-2.42B | $3.32B | $3.33B | (m) | (m) | 12 month · $39.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-02-28 | $0.00 | $62.00K | $5.72B | (m) | $-42.95M | $-2.28B | $3.40B | $3.41B | (m) | (m) | 3 month · $9.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-11-30 | (m) | $61.00K | $5.70B | (m) | $-121.45M | $-1.11B | $4.47B | $4.48B | (m) | (m) | 3 month · $10.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-08-31 | (m) | $60.00K | $5.64B | (m) | $-79.73M | $-1.04B | $4.53B | $4.56B | (m) | (m) | 3 month · $9.19M | (m) | (m) | (m) | (m) | 3 month · $9.05M | (m) | (m) | (m) |
| 2022-05-31 | $0.00 | $53.00K | $5.38B | (m) | $-20.76M | $-962.85M | $4.40B | $4.44B | (m) | (m) | 12 month · $35.99M | (m) | (m) | (m) | (m) | (m) | 12 month · $52.99M | (m) | (m) |
| 2022-03-31 | (m) | $53.00K | $5.38B | (m) | $-20.76M | $-962.85M | $4.40B | $4.44B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-02-28 | (m) | $48.00K | $5.11B | (m) | $1.01M | $-484.71M | $4.63B | $4.66B | (m) | (m) | 3 month · $9.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-11-30 | (m) | $46.00K | $4.95B | (m) | $9.60M | $-527.90M | $4.44B | $4.47B | (m) | (m) | 3 month · $12.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-08-31 | (m) | $46.00K | $4.80B | (m) | $51.25M | $-527.70M | $4.32B | $4.39B | (m) | (m) | 3 month · $9.42M | (m) | (m) | (m) | (m) | (m) | 3 month · $52.99M | (m) | (m) |
| 2021-05-31 | (m) | $46.00K | $4.79B | (m) | $152.67M | $-486.05M | $4.46B | $4.47B | (m) | (m) | 12 month · $19.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2021-03-31 | (m) | (m) | (m) | (m) | $11.96M | $-1.07B | $540.63M | (m) | (m) | (m) | 3 month · $7.14M | (m) | (m) | $1.60B | (m) | (m) | (m) | (m) | (m) |
| 2021-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.09B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | $8.21M | $-730.10M | $373.90M | (m) | (m) | (m) | 12 month · $29.72M | (m) | (m) | $1.10B | 12 month · $2.21M | (m) | (m) | (m) | (m) |
| 2020-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.35B | (m) | (m) | 3 month · $1.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | $2.69M | $-727.16M | $186.72M | (m) | (m) | (m) | 3 month · $8.08M | (m) | (m) | $911.17M | 3 month · $1.49M | (m) | (m) | (m) | (m) |
| 2020-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.27B | (m) | (m) | 3 month · $1.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $231.00K | $-724.84M | $131.49M | (m) | (m) | (m) | 3 month · $7.65M | (m) | (m) | $856.08M | (m) | (m) | (m) | (m) | (m) |
| 2020-05-31 | (m) | $24.00K | $1.37B | (m) | $-5.43M | $-113.35M | $1.25B | $1.27B | (m) | (m) | 12 month · $18.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-6.99M | $-643.15M | $190.31M | (m) | (m) | (m) | 3 month · $7.68M | (m) | (m) | $840.44M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $9.72M | $-430.13M | $285.27M | (m) | (m) | (m) | 12 month · $31.84M | (m) | (m) | $705.67M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | $1.69M | $-209.21M | $415.61M | (m) | (m) | (m) | 3 month · $8.64M | (m) | (m) | $623.25M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | $6.86M | $-173.53M | $360.06M | (m) | (m) | (m) | 3 month · $7.92M | (m) | (m) | $526.83M | 3 month · $70.00K | (m) | (m) | (m) | (m) |
| 2019-05-31 | (m) | (m) | (m) | (m) | $900.00K | (m) | (m) | $1.23B | (m) | (m) | 12 month · $29.03M | (m) | (m) | (m) | (m) | (m) | 12 month · $7.14M | (m) | $0.00 |
| 2019-03-31 | (m) | (m) | (m) | (m) | $4.70M | $-138.48M | $381.91M | (m) | (m) | (m) | 3 month · $5.74M | (m) | (m) | $515.69M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $3.76M | $-108.18M | $197.65M | (m) | (m) | 12 month · $41.95M | 12 month · $20.99M | (m) | (m) | $302.06M | 12 month · $2.85M | 12 month · $-8.81M | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | $3.33M | $-77.17M | $188.11M | (m) | (m) | (m) | 3 month · $11.24M | (m) | (m) | $261.94M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $1.00K | $8.00K | (m) | (m) | $3.78M | $-58.47M | $35.33M | (m) | (m) | (m) | 3 month · $5.60M | (m) | (m) | $89.92M | (m) | (m) | (m) | (m) | (m) |
| 2018-05-31 | (m) | (m) | (m) | (m) | $2.95M | (m) | (m) | $813.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $42.65M | (m) | (m) | (m) | 3 month · $31.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | $3.87M | $-40.45M | $-4.85M | (m) | (m) | (m) | 12 month · $139.00K | (m) | (m) | $31.74M | (m) | (m) | (m) | 12 month · $8.00K | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $2.53M | (m) | (m) | (m) | 12 month · $94.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $9.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |